This inventor holds 3 USPTO granted patents, plus 2 CIPO patents and 2 EPO patents. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2016-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016-2017
Title: Takahiro Okachi: Innovator in Pyrrole Derivatives
Introduction
Takahiro Okachi is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of chemistry, particularly in the development of pyrrole derivatives. With a total of three patents to his name, Okachi's work is recognized for its innovative approach and potential applications.
Latest Patents
Okachi's latest patents include a method for producing an atropisomer of a pyrrole derivative. This invention provides a production intermediate of an atropisomer that exhibits excellent mineralocorticoid receptor antagonistic activity. The method involves resolving a compound represented by a specific general formula into its atropisomers, utilizing an optically active amine with a cinchonine skeletal formula. Additionally, he has developed a crystal of (S)-1-(2-hydroxyethyl)-4-methyl-N-[4-(methylsulfonyl)phenyl]-5-[2-(trifluoromethyl)phenyl]-1H-pyrrole-3-carboxamide.
Career Highlights
Takahiro Okachi is currently employed at Daiichi Sankyo Company, Limited, where he continues to advance his research in medicinal chemistry. His work has garnered attention for its potential therapeutic applications, particularly in the treatment of conditions related to mineralocorticoid receptors.
Collaborations
Okachi collaborates with esteemed colleagues such as Masashi Watanabe and Michiaki Kawahara. Their combined expertise contributes to the innovative research environment at Daiichi Sankyo.
Conclusion
Takahiro Okachi's contributions to the field of pyrrole derivatives highlight his role as a significant inventor in the pharmaceutical industry. His innovative methods and collaborative efforts continue to pave the way for advancements in medicinal chemistry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
